ArticleBMJ open2019

Study protocol for a randomised, double-blind, placebo-controlled clinical trial of duloxetine for the treatment and prevention of musculoskeletal pain: altering the transition from acute to chronic pain (ATTAC pain).

Daniel H Strauss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.